Video | Business Headlines | Internet | Science | Scientific Ethics | Technology | Search

 


Huntington’s research results in treatment advance

Huntington’s research results in treatment advance

Treatment of Huntington’s disease may become more targeted and individualised as a result of research at the University of Auckland’s Centre for Brain Research.

Scientists have for decades strived to understand why Huntington’s disease, which is caused by a single gene mutation, can produce such variable symptoms.

Post-doctoral researcher, Dr Eric Kim with his supervisor, Distinguished Professor Richard Faull, have found that different Huntington’s disease symptoms are characterised by cell loss in different functional regions of the brain, suggesting a possible direction for developing targeted therapies.

In patients with severe motor and movement disorders, there was significant cell loss only in the motor cortex, (a region that regulates movement). In patients with severe behavioural and mood affected disorders, they found the opposite – that there was significant cell loss in the limbic cortex, (a region which regulate mood and behaviour), and not in the motor cortex.

“This is direct evidence to show the structural or anatomical origins of the symptom variability in Huntington’s disease, and shows why some people manifest with different symptom profiles in Huntington’s disease,” says Dr Kim, who was involved in this work over the past four years. “It also showed us that every individual Huntington’s disease patient is slightly different in the way their symptoms show up in the brain.”

“Even studies on a pair of identical twins that share the same genetic background, show different symptom profiles,” he says.

The study team used tissue from the Centre’s Human Brain Bank and characterised 13 Huntington’s disease patients and compared it to 15 normal control brains at the cellular level.
It’s already known from previous research over the past two decades that Huntington’s disease is caused by a single gene mutation that produces a mutant protein which forms aggregates within the neurons. The formation of these aggregates is known to cause an array of molecular changes that ultimately results in overt clinical symptoms associated with Huntington’s disease.

Although it is caused by a single gene, there are major variations in the symptoms of Huntington’s disease. The pattern of symptoms exhibited by each individual can differ considerably and present as varying degrees of jerky movements, mood and behavioural changes, and cognitive decline such as memory loss.

Recent investigations have focused on what the defective gene does to various structures in the brain and understanding the relationship between changes in the brain and the variable symptom profiles in Huntington’s disease.

Analyses of post-mortem human Huntington’s disease tissue suggest that variation in clinical symptoms is strongly associated with degeneration in two major regions of the brain, the striatum of the basal ganglia and the cerebral cortex.

The brain mass at the base of the brain – the basal ganglia – has strong connections with the lining of the outer layer of the brain – the cerebral cortex, says Dr Kim. The cerebral cortex initiates signals that are interpreted by the basal ganglia.

“There are already well validated studies that the cerebral cortex and the basal ganglia are severely affected in Huntington’s disease,” he says. “That work is done using magnetic resonance imaging (MRI) with researchers from Boston at the forefront of that research.”
The brains of Huntington’s disease patients show severe atrophy in both the basal ganglia and the cerebral cortex.

As MRIs can show the region of the brain affected, but not what is happening at the cellular level, another approach was needed to find the different cell types involved in each of the disease processes.

“We decided to characterise 13 Huntington’s disease patient cases and compare them to 15 normal control cases,” says Dr Kim. “We focussed our study on the motor cortex for movement symptoms and the limbic cortex for mood and behavioural symptoms.”

The study team worked with psychologists, Dr Lynette Tippett and Virginia Hogg from the University’s Department of Psychology, who did clinical data analysis on the clinical symptom profiles for each case.

“We divided the patient group between those who had mainly behavioural symptoms and those with predominantly motor symptoms, and found that there were major differences in terms of cell loss in the motor cortex and limbic cortex, “ he says.

“There, a major cell loss in the motor cortex was only observed in the patient group with predominant motor symptoms and a major cell loss in the limbic cortex was only observed in the patient group with mainly behavioural symptoms.”

“This suggests that our own recent detailed quantitative study in the post-mortem human Huntington’s disease brain has complemented and expanded the neuroimaging studies by providing a cellular basis of symptom variability in Huntington’s disease,” says Dr Kim. At present, there are several treatment strategies for Huntington’s disease under study.

These include cell transplants, gene therapy, and approved drugs to manage or alleviate the symptoms.

“We now believe our research shows that individualised symptoms need targeted treatments.”

The research formed part of Dr Kim’s doctorate that he has followed up in his post-doctoral research studies.

The research was published in a highly rated clinical neurology journal, the Annals of Neurology. It was supported by a grant from the Health Research Council of New Zealand, Neurological Foundation of New Zealand and the Auckland Medical Research Foundation.

ENDS

© Scoop Media

 
 
 
 
 
Business Headlines | Sci-Tech Headlines

 

Housing: Affordability Drops 14%, Driven By Auckland Prices

Housing affordability across New Zealand fell 14 percent in the year ending November 2014, with Auckland’s lack of affordability set to reach levels it hit during the height of the global financial crisis, according to the latest Massey University Home Affordability Report More>>

ALSO:

The Dry: Fonterra Drops Forecast Milk Volumes By 3.3 Percent

Fonterra Cooperative Group, the worlds largest dairy exporter, reduced its milk volume forecast for the 2014-2015 season by 3.3 per cent due to the impact of dry weather on production in recent weeks. More>>

ALSO:

Strike: Lyttelton Port Workers Vote To Escalate Dispute

Members of the Rail and Maritime Transport Union (RMTU) at Lyttelton Port today voted to escalate their industrial action. Around 200 RMTU members have been operating an overtime ban since 17 December and today they endorsed a series of full withdrawals of labour at the port. More>>

ALSO:

Scoop Business: NZ Dollar Falls To 3-Year Low As Investors Favour Greenback

The New Zealand dollar fell to its lowest in more than three years as investors sold euro and bought US dollars, weakening other currencies against the greenback. More>>

ALSO:

Scoop Business: NZ Govt Operating Deficit Smaller Than Expected

The New Zealand’s government’s operating deficit was smaller than expected in the first five months of the financial year as a clampdown on expenditure managed to offset a shortfall in the tax-take from last month’s forecast. More>>

ALSO:

0.8 Percent Annually:
NZ Inflation Falls Below RBNZ's Target

New Zealand's annual pace of inflation slowed to below the Reserve Bank's target band in the final three months of the year, giving governor Graeme Wheeler more room to keep the benchmark interest rate lower for longer.More>>

ALSO:

Get More From Scoop

 
 
Standards New Zealand

Standards New Zealand
 
 
 
 
 
 
 
 
Sci-Tech
Search Scoop  
 
 
Powered by Vodafone
NZ independent news